U.S. Food and Drug Administration
The Immediate FDA and NCI Studies on Menthol: A Step Forward or Puffery?
Published in Medical Letter on the CDC and FDA, December 12th, 2010
The Supplement consists of one Editorial, three Commentaries and eleven Research Reports.
The objectivity of the articles differs substantially; one of the Commentaries could be classified as puffery and elements of the Editorial are on the edge. CRE has not reviewed the Research Reports in detail, but CRE has reviewed the most significant initiation/cessation studies identified by FDA.
With respect to the Supplement CRE concludes that the Editorial and Commentaries are merely hearsay and have no...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Daniels Sharpsmart
Study Shows Healthcare Worker Needlestick Injuries Dramatically Reduced Through Use of Safety Feature-Enhanced Needle Disposal Device - Nanotechnology - Silver Nanoparticles
New findings from K. Chaloupka and co-authors in the area of nanotechnology - silver nanoparticles published - American Chemical Society
Latest American Chemical Society podcast: New water filter kills disease-causing bacteria - Coxiella burnetii
Investigators at Yale University zero in on coxiella burnetii - Nephrology
Reports outline nephrology research from Army - Community Health
New community health study findings have been published by A.L. Flores and colleagues - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
